Kenvue Inc. (J4D)
XSTU
Closed
Sep 22, 2026
Day's Range
15.2552 wk Range
11.90Overview - J4D - Kenvue Inc.
Key Statistics
Valuation
Enterprise Value
33.01B
P/E (Trailing)
‪21.99‬
PEG Ratio
‪2.41‬
Price / Sales (TTM)
‪2.00‬
Price / Book
‪3.38‬
EV / EBITDA
‪11.01‬
Profitability
Gross Margin
‪58.17%‬
Profit Margin
‪10.76%‬
Operating Margin
‪19.41%‬
Return on Assets
‪6.99%‬
Return on Equity
‪15.58%‬
Ownership
Shares Outstanding
1.92B
Float
1.91B
Held by Insiders
‪0.07%‬
Held by Institutions
‪96.01%‬
Price stats
Beta
‪0.42‬
50-Day Avg
‪16.63‬
200-Day Avg
‪15.41‬
Dividends
Payout Ratio
‪97.65%‬
Frequency
Quarterly
Market Cap - J4D - Kenvue Inc.
Peers - J4D - Kenvue Inc.
Peer Comparison
Compared with companies in Household & Personal Products listed on XSTU.
- J4DXSTUKenvue Inc.30.61BMarket Cap+0.10%52-week change22.00P/E (Trailing)‪10.76%‬Profit Margin
- HEN1XSTUHenkel KGaA Sponsored ADR30.44BMarket Cap+2.13%52-week change15.93P/E (Trailing)‪9.35%‬Profit Margin
- SARXSTUZozo Inc.4.98BMarket Cap-21.26%52-week change11.57P/E (Trailing)‪93.26%‬Profit Margin
- 0EFXSTUe.l.f. Beauty, Inc.2.98BMarket Cap-24.39%52-week change199.02P/E (Trailing)‪70.72%‬Profit Margin
- BIF0XSTUBIC S.A.2.63BMarket Cap+20.25%52-week change22.76P/E (Trailing)‪5.74%‬Profit Margin
- 49KXSTUKose Corporation1.78BMarket Cap-9.68%52-week change23.91P/E (Trailing)‪4.09%‬Profit Margin
- ORNXSTUOryzon Genomics S.A.214.40MMarket Cap-6.86%52-week change-69.45P/E (Trailing)—Profit Margin
Profile Summary - J4D - Kenvue Inc.
About
Kenvue Inc. is a consumer health company focused on everyday care products across self care, skin health and beauty, and essential health. Kenvue’s portfolio includes well-known brands such as Tylenol, Neutrogena, Aveeno, Listerine, Johnson’s, BAND-AID Brand, Zyrtec, and Nicorette, serving needs in pain relief, cough…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
